Literature DB >> 16914953

Localized injections of midazolam into the amygdala and hippocampus induce differential changes in anxiolytic-like motor activity in mice.

Scott A Heldt1, Kerry J Ressler.   

Abstract

Various strains of mice display a reliable increase in motor activity in response to benzodiazepines given at low to moderate doses. This hyperactivity has been described as both an anxiolytic-associated increase in exploratory activity and a nonspecific stimulant effect controlled by central neural mechanisms separate from those involved in the anxiolytic-like effects. The purpose of the current study was to investigate the neural circuitry underlying the hyperactivity effects of benzodiazepines in mice. Specifically, we examined the relationship between anxiety and motor activity after bilateral intra-amygdala or intra-hippocampal microinjections of the nonselective full benzodiazepine receptor agonist midazolam in C57BL/6 mice. Behavioral measures of anxiety and motor activity in open field were examined in mice given localized injections of 0, 2, 8 or 32 nmol of midazolam directed into the amygdala or hippocampus. Midazolam injected into the amygdala at the low dose produced an anxiolytic-like effect, as reflected by an increase in central open field activity. Higher doses injected into the amygdala produced a motor-depressant action, indicative of a drug-induced sedative effect. Infusions into the hippocampus produced a biphasic effect on motor activity with the two lower doses of midazolam producing a motor-stimulant action and the high dose producing a motor-depressant effect. Hippocampus injections produced no anxiolytic-like effects. The current findings demonstrate that injections of midazolam produced a regional dissociation of the anxiety-related and motor-related parameters and provide evidence that the stimulant and anxiolytic effects of benzodiazepines are independent phenomena regulated by different central mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914953      PMCID: PMC2525667          DOI: 10.1097/01.fbp.0000224386.86615.e0

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  52 in total

1.  GABAergic regulation of the central nucleus of the amygdala: implications for sleep control.

Authors:  Larry D Sanford; Brian Parris; Xiangdong Tang
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

2.  Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test.

Authors:  M C Carvalho; L Albrechet-Souza; S Masson; M L Brandão
Journal:  Braz J Med Biol Res       Date:  2005-11-09       Impact factor: 2.590

3.  Anxiolytic-like effect of paeonol in mice.

Authors:  Xiao Juan Mi; Si Wei Chen; Wen Juan Wang; Rui Wang; Yi Jing Zhang; Wei Jing Li; Yu Lei Li
Journal:  Pharmacol Biochem Behav       Date:  2005-07       Impact factor: 3.533

Review 4.  Modeling panic attacks.

Authors:  L C Schenberg; A S Bittencourt; E C Sudré; L C Vargas
Journal:  Neurosci Biobehav Rev       Date:  2001-12       Impact factor: 8.989

5.  Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors.

Authors:  E N Petersen; C Braestrup; J Scheel-Krüger
Journal:  Neurosci Lett       Date:  1985-02-04       Impact factor: 3.046

6.  Blockade of GABAA receptors in the region of the anterior basolateral amygdala of rats elicits increases in heart rate and blood pressure.

Authors:  S K Sanders; A Shekhar
Journal:  Brain Res       Date:  1991-12-13       Impact factor: 3.252

7.  Effects of midazolam on the expression of conditioned taste aversion in rats.

Authors:  Yasunobu Yasoshima; Takashi Yamamoto
Journal:  Brain Res       Date:  2005-05-10       Impact factor: 3.252

8.  Evidence for a role for dopamine in the diazepam locomotor stimulating effect.

Authors:  B Söderpalm; L Svensson; P Hulthe; K Johannessen; J A Engel
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice.

Authors:  G W M Bothe; V J Bolivar; M J Vedder; J G Geistfeld
Journal:  Genes Brain Behav       Date:  2004-06       Impact factor: 3.449

10.  GABA(A) receptors in the basolateral amygdala are involved in mediating morphine reward.

Authors:  Mohammad-Reza Zarrindast; Shamseddin Ahmadi; Ali Haeri-Rohani; Ameneh Rezayof; Mohammad-Reza Jafari; Majid Jafari-Sabet
Journal:  Brain Res       Date:  2004-04-23       Impact factor: 3.252

View more
  4 in total

1.  Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  Neuronal overexpression of Glo1 or amygdalar microinjection of methylglyoxal is sufficient to regulate anxiety-like behavior in mice.

Authors:  K M J McMurray; X Du; M Brownlee; A A Palmer
Journal:  Behav Brain Res       Date:  2015-12-19       Impact factor: 3.332

3.  Maternal Diabetes-Induced Suppression of Oxytocin Receptor Contributes to Social Deficits in Offspring.

Authors:  Jianbo Liu; Yujie Liang; Xing Jiang; Jianchang Xu; Yumeng Sun; Zichen Wang; Ling Lin; Yanbin Niu; Shiqi Song; Huawei Zhang; Zhenpeng Xue; Jianping Lu; Paul Yao
Journal:  Front Neurosci       Date:  2021-02-09       Impact factor: 4.677

4.  Maternal diabetes-mediated RORA suppression in mice contributes to autism-like offspring through inhibition of aromatase.

Authors:  Hong Yu; Yanbin Niu; Guohua Jia; Yujie Liang; Baolin Chen; Ruoyu Sun; Min Wang; Saijun Huang; Jiaying Zeng; Jianpin Lu; Ling Li; Xiaoling Guo; Paul Yao
Journal:  Commun Biol       Date:  2022-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.